Our Story

How did it all begin?

Parth Khanna (Chief Executive Officer), Kapil Kalra (Chief Revenue Officer), and Kumar Erramilli (Chief Technology Officer) met and were roommates as undergraduate students at the University of Waterloo. While they were each drawn to different academic studies, they shared a desire to make a positive impact on the world. After graduating, they each went their separate ways to pursue this desire through careers in law, business consulting, and technology, respectively; however, it wasn’t long before their paths would cross again.

In 2014, the three friends came together—drawn again by their shared intention of making a meaningful impact—and defined their vision for ACTO. Founded on the core values of changing lives, being human, and challenging the status quo to solve problems, ACTO has grown to become a leader in AI-powered solutions for Life Sciences that help ensure field professionals are always competent and confident in face-to-face HCP interactions.

Our Timeline

2014

ACTO was Born

ACTO was founded on July 21, 2014 as an industry agnostic solution, on proven learning pedagogies of microlearning and action-based learning to drive behavior change and employee engagement

2015

Angel Round

ACTO secures an angel round of funding to build an innovative enterprise technology solution for learning management

2016

Rapid Adoption

ACTO gains rapid cross-industry adoption in commercial learning, with significant traction in the Life Sciences industry

2017

Focus on Life Sciences

ACTO gathers a select cohort of Life Sciences leaders to understand the unique requirements of pharma and med device training

2018

Seed funding

ACTO secures seed funding from MaRS IAF, Extreme Venture Partners, and Panache Ventures to scale the business

2019

Platform and market expansion

ACTO delivers capabilities specific to the needs of Life Sciences trainers and learners, and demand for the platform surges

2020

Series A and two acquisitions

ACTO secures US $11.5 million Series A funding led by Resolve Growth Partners and acquires Scrimmage and CoHealth

2021

Significant growth

ACTO gains significant market share, grows its partner network, and expands its executive team to become the #1 learning platform in Life Sciences

2022

Series B financing

ACTO secures US$18M Series B financing led by Questa Capital to accelerate continued innovation and growth

2023

A Major Contender

ACTO is recognized as a Major Contender in Everest Group’s Life Sciences Next-generation Customer Engagement Platforms (CEP) PEAK Matrix® Assessment 2023

2024

Another Strategic Acquisition

ACTO acquires 4th Down Solutions, adding to steady organic customer growth in Top 50 Pharma

2025

ACTO launches the first and only AI-simulated roleplay solution

Exclusively designed for Life Sciences and integrated with Veeva PromoMats and MedComms

Careers

The ACTO Team

Where work is fun!

“We are thrilled to have the opportunity to partner with ACTO. The company’s founding team embodies the hunger, humility, and customer obsession that we love to see in entrepreneurs.”

~ Chris Rhodes, Co-Founder and Managing Director Resolve Growth Partners

“ACTO’s early focus and deep expertise in AI, along with their demonstrated success in solving challenges faced by pharma companies, positions them to best lead the AI charge on the commercial side of life sciences.”

~ Ryan Drant, Founder and Managing Partner, Questa Capital Management

“We see ACTO as a category leader with their powerful AI-first platform, which empowers pharma companies to consistently turn their field reps into top performers. We’re excited to see ACTO driving this transformation in the industry.”

~ Jit Sinha, Co-Founder and Partner, Resolve Growth Partners

Interested?

Want to see what intelligent field excellence in Life Sciences looks like? Get a personalized product demo of ACTO today!